# Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

> **NCT07500129** · — · NOT_YET_RECRUITING · sponsor: **Atlas University** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer
- Invasive Breast Carcinoma
- Exosomal microRNA
- Neoadjuvant Chemotherapy Response
- Pathological Complete Response

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07500129
- **Lead sponsor:** Atlas University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-12
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-04-22
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07500129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07500129, "Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07500129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*